17 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp00150 | Citropin modified peptide-15 | GLFAVIKKVASVIKGL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Leukemia tumor cell line | Leukemia cancer | IC50 : 5 M |
| dbacp00151 | Citropin modified peptide-15 | GLFAVIKKVASVIKGL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Lung tumor cell line | Lung cancer | IC50 : 5 M |
| dbacp00152 | Citropin modified peptide-15 | GLFAVIKKVASVIKGL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Colon tumor cell line | Colon cancer | IC50 : 5 M |
| dbacp00153 | Citropin modified peptide-15 | GLFAVIKKVASVIKGL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Brain tumor cell line | Brain tumor | IC50 : 5 M |
| dbacp00154 | Citropin modified peptide-15 | GLFAVIKKVASVIKGL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Skin tumor cell line | Skin cancer | IC50 : 5 M |
| dbacp00155 | Citropin modified peptide-15 | GLFAVIKKVASVIKGL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Ovary tumor cell line | Ovarian cancer | IC50 : 5 M |
| dbacp00156 | Citropin modified peptide-15 | GLFAVIKKVASVIKGL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Liver tumor celline | Liver cancer | IC50 : 5 M |
| dbacp00157 | Citropin modified peptide-15 | GLFAVIKKVASVIKGL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Prostate tumor cell line | Prostate cancer | IC50 : 5 M |
| dbacp00158 | Citropin modified peptide-15 | GLFAVIKKVASVIKGL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Breast tumor cell line | Breast cancer | IC50 : 5 M |
| dbacp00805 | A4K14-citropin1.1 | GLFAVIKKVASVIKGL | Synthetic construct | Cell membrane disintegration | CCK-8 test | C4-2B | Prostate cancer | IC50 : 29.05 μM |
| dbacp00806 | A4K14-citropin1.1 | GLFAVIKKVASVIKGL | Synthetic construct | Cell membrane disintegration | CCK-8 test | C4-2B | Lung cancer | IC50 : 29.05 μM |
| dbacp00807 | A4K14-citropin1.1 | GLFAVIKKVASVIKGL | Synthetic construct | Cell membrane disintegration | CCK-8 test | A549 | Prostate cancer | IC50 : 14.97 μM |
| dbacp00808 | A4K14-citropin1.1 | GLFAVIKKVASVIKGL | Synthetic construct | Cell membrane disintegration | CCK-8 test | A549 | Lung cancer | IC50 : 14.97 μM |
| dbacp00809 | A4K14-citropin1.1 | GLFAVIKKVASVIKGL | Synthetic construct | Cell membrane disintegration | CCK-8 test | U87 | Prostate cancer | IC50 : 14.8 μM |
| dbacp00810 | A4K14-citropin1.1 | GLFAVIKKVASVIKGL | Synthetic construct | Cell membrane disintegration | CCK-8 test | U87 | Lung cancer | IC50 : 14.8 μM |
| dbacp00811 | A4K14-citropin1.1 | GLFAVIKKVASVIKGL | Synthetic construct | Cell membrane disintegration | CCK-8 test | MCF-7 | Prostate cancer | IC50 : 14.16 μM |
| dbacp00812 | A4K14-citropin1.1 | GLFAVIKKVASVIKGL | Synthetic construct | Cell membrane disintegration | CCK-8 test | MCF-7 | Lung cancer | IC50 : 14.16 μM |